Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 May 2019
Historique:
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 22 5 2019
Statut: epublish

Résumé

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Identifiants

DOI: 10.1038/s41598-019-43988-9 PMID: 31110193 PMC: PMC6527692
pubmed: 31110193
doi: 10.1038/s41598-019-43988-9
pii: 10.1038/s41598-019-43988-9
pmc: PMC6527692
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

7851

Commentaires et corrections

Type : ErratumFor

Auteurs

Karen S Cheung Tung Shing (KS)

ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Sophie E Broughton (SE)

ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Tracy L Nero (TL)

ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Kevin Gillinder (K)

Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, Victoria, 3004, Australia.

Melissa D Ilsley (MD)

Mater Research, University of Queensland and Metro South Health Care, South Brisbane, Queensland, 4101, Australia.

Hayley Ramshaw (H)

Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, 5000, Australia.

Angel F Lopez (AF)

Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, 5000, Australia.

Michael D W Griffin (MDW)

Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Michael W Parker (MW)

ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia.

Andrew C Perkins (AC)

Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, Victoria, 3004, Australia.

Urmi Dhagat (U)

ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia. urmi.dhagat@unimelb.edu.au.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, 3010, Australia. urmi.dhagat@unimelb.edu.au.
ORCID: 0000-0002-5650-5767

Classifications MeSH